Long COVID: Current Status in Japan and Knowledge About Its Molecular Background

April 2022 in “ Global health & medicine ”

Akira Matsunaga, Shinya Tsuzuki, Shigefumi Morioka, Norio Ohmagari, Yukihito Ishizaka

long COVID SARS-CoV-2 autoimmunity inflammatory reactions psychiatric impairment neurotropic RNA viral proteins persistent infection vaccination

Studysummary This review explores long COVID symptoms in Japan and discusses potential contributing factors, highlighting persistent SARS-CoV-2 infection's role, but reports no new clinical results; it also considers vaccination as a treatment option.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jstage.jst.go.jp →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Pathological Sequelae of Long-Haul COVID

353 citations , February 2022 in “Nature Immunology”

This review explores post-COVID-19 syndromes and the underlying mechanisms, including persistent inflammation, autoimmunity, and possible viral reservoirs, but reports no new clinical results.

research Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study

202 citations , January 2022 in “Journal of Clinical Medicine”

This study found that female COVID-19 survivors were more likely than males to experience multiple long-term post-COVID symptoms, including fatigue, pain, hair loss, and mood disorders.

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

1250 citations , August 2021 in “Scientific Reports”

In this study, researchers estimated that 80% of patients infected with SARS-CoV-2 experienced at least one long-term symptom, with fatigue being the most common.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.

research Shedding Light on Therapeutics in Alopecia and Their Relevance to COVID-19

7 citations , December 2020 in “Clinics in Dermatology”

This article reviews the use of various treatments for alopecia and their potential impact on COVID-19 outcomes, emphasizing the importance of patient registries in generating real-world evidence; it reports no new results.

research Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019

88 citations , October 2020 in “Open Forum Infectious Diseases”

This study discusses hair loss as a potential late-onset symptom of COVID-19 recovery, with androgenic alopecia and telogen effluvium suggested as possible causes, but provides no new clinical results.